- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01634009
Soy-Ready to Use Therapeutic Food (RUTF) in Severely Malnourished Children
Efficacy of Ready to Use Therapeutic Food Using Soy Protein Isolate in Under-5 Children With Severe Acute Malnutrition in Bangladesh
SAM defined by having weight-for-height (WH) less than - 3 Z score or bi-pedal nutritional edema is an important cause of death in children globally including Bangladesh. The death rate among children hospitalized for SAM is still high. Severe malnutrition in children can be successfully treated by using WHO guidelines with or without minor modification. Since the Community Based Therapeutic Care (CTC)/CMAM approach was developed, the use of RUTF for the treatment of children with SAM has gained ground, and huge amounts of RUTF are used particularly in African countries. RUTFs are an energy-dense lipid paste enriched with vitamins and minerals. The typical composition (ingredient % of weight) of RUTF is whole milk powder 30%; sugar 28%; vegetable oil 15.4%; peanut paste 25%; and mineral vitamin mix 1.6%. Although the CTC model promises treatment of SAM at a considerably lower cost than the previous inpatient model, the cost of RUTF is still considered a significant barrier to universal roll-out of SAM treatment and has made CTC implementation too expensive in many high-need countries.
The single most expensive raw ingredient in RUTF is milk powder, contributing around 50% of raw ingredient cost or between 30-35% of the total cost of the final product. Isolated soy protein has a cost per kg protein that normally is below that of skim or whole milk powder, and can thus reduce the total cost of RUTF. In addition, isolated soy protein (ISP) is a high quality, complete protein that meets the daily protein requirements of growing children and adults. ISP is a highly digestible protein [FAO/WHO, 1991] with an amino acid profile that has been shown to achieve a Protein Digestibility-Corrected Amino Acid Score (PDCAAS) of 1.00, comparable to milk and eggs, and has been shown to maintain nitrogen balance when fed as the sole protein source at minimum recommended intake levels.
To compare the efficacy (weight gain, rate of weight gain and change of lean body mass) of the standard RUTF and an RUTF made from ISP (Soy-RUTF) through a randomized double masked intervention trial 300 SAM children aged 6 to 59 months after completion of their stabilization phase from the Dhaka Hospital of icddr,b Bangladesh will be studied. They will randomly receive standard- or Soy-RUTF as take home and followed up (weekly until achieving -2 WHZ, and thereafter fortnightly until achieving -1 WHZ) at the nutrition follow up unit at the outpatient department of this Dhaka Hospital of icddr,b.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Dhaka, Bangladesh, 21212
- Icddr,b
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- children (both boys and girls) with SAM defined by WH < -3 Z score of WHO standard,
- completed acute (stabilization) phase management,
- clinically well,
no edema and regaining appetite and aged 6 to 60 months will be included. - additional enrollment criteria will be as follows:
- no signs of concurrent infection,
- mothers/caregivers agreed to stay in their current address for next 4 months (for tracking the children)
Exclusion Criteria:
- failure to obtain consent from parents or caretakers;
- children without any fixed address;
- children with tuberculosis or any congenital/acquired disorder affecting growth i.e. trisomy-21 or cerebral palsy;
- children on an exclusion diet for the treatment of persistent diarrhea,
- having history of soy, peanut or milk protein allergy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard RUTF (control)
Children will receive standard RUTF in this arm and will be considered as control arm
|
Soy-based RUTF will be given in double blind manner
Other Names:
|
|
No Intervention: Standard RUTF
Will act as control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To compare the efficacy (rate of weight gain)
Time Frame: 31 December 2014 (up to 3 years)
|
By 31st December 2014 we shall be able to complete the enrollment, data analyses and preliminary/draft report writting.
|
31 December 2014 (up to 3 years)
|
Collaborators and Investigators
Investigators
- Principal Investigator: MD IQBAL HOSSAIN, DCH, PhD, International Centre for Diarrhoeal Disease Research, Bangladesh
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PR-09038
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Acute Malnutrition
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedUncomplicated Severe Acute MalnutritionBurkina Faso
-
Society for Applied StudiesWorld Health Organization; Christian Medical College, Vellore, India; ArthCompletedUncomplicated Severe Acute MalnutritionIndia
-
National Institute for Medical Research, TanzaniaLondon School of Hygiene and Tropical Medicine; University of Turku; Rigshospitalet... and other collaboratorsNot yet recruitingSevere Acute Malnutrition in ChildhoodTanzania
-
International Centre for Diarrhoeal Disease Research...UNICEF; NutrisetCompletedSevere Acute Malnutrition in ChildhoodBangladesh
-
UNICEFSave the ChildrenCompletedSevere MalnutritionCongo, The Democratic Republic of the
-
Aga Khan UniversityAction Contre la FaimCompletedEvaluation of the Effectiveness and Impact of Community Case Management of Severe Acute MalnutritionSevere MalnutritionPakistan
-
International Centre for Diarrhoeal Disease Research...UNICEFNot yet recruitingMalnutrition SevereBangladesh
-
Action Against Hunger USAUniversity of Washington; Ethiopian Public Health InstituteRecruitingModerate Acute Malnutrition | Severe Acute MalnutritionEthiopia
-
Microbiome Health Research InstituteUniversity of Cape TownTerminatedModerate Acute Malnutrition | Severe Acute MalnutritionSouth Africa
-
University of OxfordLondon School of Hygiene and Tropical Medicine; University College, London; KEMRI-Wellcome... and other collaboratorsUnknownAntibiotic Resistance | Malnutrition Severe | Antibiotic ToxicityKenya, Uganda
Clinical Trials on Soy-based RUTF (in double blind design)
-
International Food Policy Research InstituteInstitut de Recherche en Sciences de la Sante, Burkina Faso; AFRICSanteCompletedWasting | Moderate Acute Malnutrition | Severe Acute MalnutritionBurkina Faso
-
Universidad VeracruzanaCompleted
-
Glycomine, Inc.Active, not recruitingPhosphomannomutase 2 Deficiency | PMM2-CDGSpain, United States, Italy, Germany, Poland, Belgium, United Kingdom, France, Portugal, Czechia
-
University of the PunjabCompleted
-
Shanghai Changzheng HospitalNot yet recruiting
-
AstraZenecaCompletedGastroesophageal Reflux Disease (GERD)United States, France, Poland, Germany
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Vanda PharmaceuticalsTerminatedGeneralized Pustular PsoriasisUnited States, Australia, France, Georgia, Germany, Malaysia, Morocco, Poland, Romania, South Korea, Spain, Taiwan, Thailand, Tunisia, Turkey (Türkiye)
-
Kasr El Aini HospitalCompleted
-
Nutrition Institute, SloveniaSlovenian Research Agency; Higher School of Applied Sciences (VIST); Valens Int...CompletedVitamin D DeficiencySlovenia